Updated

A year after President Trump pledged to lower Medicaid drug prices, it remains unclear which drugs will actually be affected by the promised changes, as implementation depends on individual states choosing to opt in. The lack of clarity has left patients and advocates uncertain about whether the administration's drug pricing promises will translate into real savings.